首页 >
法规速递
-
Document: Procedural advice on publication of information on withdrawals of marketing authorisation and variation applications for veterinary medicinal products-2025/9/24
2025-09-25查看详情 > -
Document: Consultation on an ancillary medicinal substance incorporated in a medical device - XVIVO Heart Solution-2025/11/3
2025-11-04查看详情 > -
Page: Outcomes of imposed non-interventional post-authorisation safety studies-2025/12/2
2025-12-03查看详情 > -
Document: PRAC recommendations on signals adopted at the 24-27 November 2025 PRAC meeting-2026/1/6
2026-01-07查看详情 > -
Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2026/2/10
2026-02-11查看详情 > -
Document: Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI)-2026/3/19
2026-03-20查看详情 > -
国家药监局药审中心关于发布《上市后变更补充申请事项及受理时启动注册检验情形的说明表》的通知-2026/4/23
2026-04-24查看详情 > -
Page: Artificial intelligence-2026/6/4
2026-06-05查看详情 > -
Document: Questions and answers on Article 13 referral procedures-2026/7/16
2026-07-17查看详情 > -
国家药监局关于发放药品电子注册证的公告（2022年 第83号）-2022/10/9
2022-11-14查看详情 >
